atrn-119
Generic: Mosipasertib·Code: ATRN-119
atrn-119: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Aprea Therapeutics, Inc. (APRE) | Phase 1 |
Get deeper analysis on atrn-119
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis